CD34+ immunoselection of autologous grafts for the treatment of high-risk neuroblastoma-Reference-Cited by-同舟云学术

CD34+ immunoselection of autologous grafts for the treatment of high-risk neuroblastoma

Published:2010-11-05 Issue:1 Volume:56 Page:134-142
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr. Blood Cancer

Author:

Marabelle Aurélien,Merlin Etienne,Halle Pascale,Paillard Catherine,Berger Marc,Tchirkov Andrei,Rousseau Raphaël,Leverger Guy,Piguet Christophe,Stephan Jean-Louis,Demeocq François,Kanold Justyna

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.22840/fullpdf

Reference59 articles.

1. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group;Matthay;N Engl J Med,1999

2. Clonogenicity of circulating neuroblastoma cells: Implications regarding peripheral blood stem cell transplantation;Moss;Blood,1994

3. Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells;Rill;Blood,1994

4. Clonogenicity of circulating neuroblastoma cells: Implications regarding peripheral blood stem cell transplantation;Moss;Blood,1994

5. High-dose melphalan with 6-hydroxydopamine-purged autologous bone marrow transplantation for poor-risk neuroblastoma;Kushner;Cancer,1991

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Arsenic trioxide induces ferroptosis in neuroblastoma by mediating GPX4 transcriptional inhibition;Clinical and Translational Science;2024-01

2. Stem Cell Therapy for High-Risk Neuroblastoma: Stem Cell Transplantation and Targeting Cancer Stem Cells;Comprehensive Hematology and Stem Cell Research;2024

3. Stammzelltransplantation bei pädiatrischen soliden Tumoren;Der Onkologe;2021-03-09

4. Significance of hematopoietic surface antigen CD34 in neuroblastoma prognosis and the genetic landscape of CD34-expressing neuroblastoma CSCs;Cell Biology and Toxicology;2020-09-26

5. Label-free neuroblastoma cell separation from hematopoietic progenitor cell products using acoustophoresis - towards cell processing of complex biological samples;Scientific Reports;2019-06-19